Qianhai Health Holdings publishes 2025 annual report

• Qianhai Health Holdings published its 2025 annual report, highlighting continued focus on electronic components while moving to diversify product offering.
• Electronic component trading benefited from strong semiconductor demand tied to AI, 5G, data centers, and automotive electronics, though wafer shortages constrained volumes.
• Procurement strategy shifted toward bulk buying to manage supply tightness and capture pricing moves, replacing heavier reliance on back-to-back trading.
• Health-care segment re-entered market with new products such as ginseng wine, skin-care products, and other body-care items, with supplier and customer networks still being built.
• Outlook centers on plans to invest in new manufacturing facilities in China and other locations to add services such as customization, assembly, packaging, and testing, alongside partnerships to strengthen R&D.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qianhai Health Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260429-12133653), on April 29, 2026, and is solely responsible for the information contained therein.